Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Eduardo Rodriguez-Arbolí"'
Autor:
Esther Prados de la Torre, Josefina Serrano, David Martínez-Cuadrón, Laura Torres, Claudia Sargas, Rosa Ayala, Cristina Bilbao-Sieyro, María Carmen Chillón, María José Larráyoz, Elena Soria, Clara Aparicio-Pérez, Juan M. Bergua, Teresa Bernal, Cristina Gil, Mar Tormo, Lorenzo Algarra, Juan M. Alonso-Domínguez, Eduardo Rodriguez-Arbolí, Pilar Martínez-Sanchez, Ana Oliva, Ana M. Colorado-Araujo, Carlos Rodríguez-Medina, Susana Vives, Lourdes Hermosín, Joaquín Martínez-López, Ramón García-Sanz, José A. Pérez-Simón, María José Calasanz, María Teresa Gómez-Casares, Eva Barragán, Joaquín Sánchez-García J, Pau Montesinos
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/88d6909b8970413f8083d9449f6245ae
Autor:
Jose F. Falantes, Francisco J. Márquez-Malaver, Estrella Carrillo-Cruz, Rosario M Morales-Camacho, Concepción Prats-Martín, Teresa Caballero, Eduardo Rodriguez Arbolí, Ildefonso Espigado, Jose A. Perez-Simon
Publikováno v:
Blood. 140:6920-6922
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14562f1091b3cd15188f06922e82a1f3
https://doi.org/10.1182/blood-2022-169372
https://doi.org/10.1182/blood-2022-169372
Autor:
Eduardo Rodriguez Arbolí, Catherine J. Lee, Teresa Caballero, Clara Garcia-Calderon, Carmen Martinez, Maria Aranzazu Bermudez, Lucía López Corral, Ana Triguero, Lynn E. Onstad, Stefanie Sarantopoulos, Stephanie J. Lee, Jose A. Perez-Simon
Publikováno v:
Blood. 140:10502-10504
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02b69e1ab3803f46cceb348c0a681ff9
https://doi.org/10.1182/blood-2022-158230
https://doi.org/10.1182/blood-2022-158230
Autor:
Audrey Bidet, Hubert Serve, Pierre-Yves Dumas, Carsten Müller-Tidow, Josefina Serrano, Teresa Bernal, Sarah Bertoli, Juan Bergua, Eduardo Rodriguez Arbolí, Uwe Platzbecker, Pilar Martínez-Sánchez, Martin Bornhäuser, Eric Delabesse, Adolfo de la Fuente Burguera, Christian Recher, Arnaud Pigneux, Michael Kramer, Claudia D. Baldus, David Martínez-Cuadrón, Pau Montesinos, Emilie Bérard, Cristina Gil, Christoph Röllig, Suzanne Tavitian
Publikováno v:
Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
The outcome of acute myeloid leukemia patients aged 70 years or older is poor. Defining the best treatment option remains controversial especially when choosing between intensive chemotherapy and hypomethylating agents. We set up a multicentric Europ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4fd2308cc3bead0a723ebfdc6b70e7
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15187
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15187
Autor:
Pau Montesinos, Olga Pérez-López, José A. Pérez-Simón, Enrique Colado Varela, Concepción Prats-Martín, Teresa Caballero, Maria Desamparados Sampere Talens, Covadonga Quirós Caso, Marta Segura, Eduardo Rodriguez Arbolí, Ana Yeguas Bermejo, María Belén Vidriales
Publikováno v:
Blood. 138:1821-1821
Introduction: Acute myeloblastic leukaemia (AML) is an heterogeneous disease with different molecular and prognostic characteristics. According to the comorbidities and the revised 2017 European Leukaemia genetic risk stratification (ELN17), allogene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97bce13db10531495947c6cc65efa399
https://doi.org/10.1182/blood-2021-151533
https://doi.org/10.1182/blood-2021-151533
Autor:
Beatriz Guijarro-Albaladejo, Cristina Marrero-Cepeda, Eduardo Rodríguez-Arbolí, Belén Sierro-Martínez, José Antonio Pérez-Simón, Estefanía García-Guerrero
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy with a poor prognosis despite the advent of novel therapies. Consequently, a major need exists for new therapeutic options, particularly for patients with relapsed/refractory (R/R)
Externí odkaz:
https://doaj.org/article/81603b03bcff49848b5215199be63ec6
Autor:
Claudia Sargas, Rosa Ayala, María J. Larráyoz, María C. Chillón, Eduardo Rodriguez-Arboli, Cristina Bilbao, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal, Juan Bergua, Lorenzo Algarra, Mar Tormo, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan M. Alonso-Dominguez, Raimundo García, María Luz Amigo, Pilar Herrera-Puente, María J. Sayas, Esperanza Lavilla-Rubira, Joaquín Martínez-López, María J. Calasanz, Ramón García-Sanz, José A. Pérez-Simón, María T. Gómez Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, PETHEMA cooperative study group
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Next-Generation Sequencing is needed for the accurate genetic risk stratification of acute myeloid leukemia according to European LeukemiaNet (ELN) guidelines. We validated and compared the 2022 ELN risk classification in a real-life cohort
Externí odkaz:
https://doaj.org/article/922c45afad2e435b8c679c0aca4ae8f0
Autor:
Cristina Bilbao, Ruth Stuckey, Claudia Sargas, María J Larráyoz, Maria Carmen Chillon, Rosa Ayala Diaz, Estrella Cruz Carrillo, Manuel Yébenes-Ramírez, David Martinez-Cuadron, Rebeca Rodriguez-Veiga, Cristina Gil, Teresa Bernal, Juan Miguel Bergua Burgues, Lorenzo Algarra, Mar Tormo, Maria Pilar Martinez Sanchez, Elena Soria Saldise, Josefina Serrano, Juan Manuel Alonso Dominguez, Raimundo Garcia Boyero, Maria Luz Amigo, Pilar Herrera-Puente, Maria J Sayas, Esperanza Lavilla Rubira, Carlos Rodriguez Medina, Santiago Sánchez Sosa, Jorge Rodríguez-Afonso, Paula Reyes-González-Casanova, Eduardo Rodríguez-Arbolí, Joaquin Sanchez Garcia, Joaquín Martinez-Lopez, Ramón García-Sanz, Maria Jose Calasanz, Eva Barragan, Maria Teresa Gomez Casares, Pau Montesinos
Publikováno v:
HemaSphere, Vol 7, p e93539a0 (2023)
Externí odkaz:
https://doaj.org/article/e45b6e9a8c8b4ec6b173eba95485bf28
Autor:
Eduardo Rodríguez-Arbolí, Megan Othus, Corentin Orvain, Lucas C. Zarling, Brenda M. Sandmaier, Filippo Milano, Gary Schoch, Chris Davis, H. Joachim Deeg, Frederick R. Appelbaum, Rainer Storb, Roland B. Walter
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/d58e180685d14f089ad142fed548839a
Autor:
Corentin Orvain, Jacob A. Wilson, Min Fang, Brenda M. Sandmaier, Eduardo Rodríguez-Arbolí, Brent L. Wood, Megan Othus, Frederick R. Appelbaum, Roland B. Walter
Publikováno v:
Haematologica, Vol 108, Iss 2 (2022)
Measurable residual disease (MRD) before hematopoietic cell transplantation (HCT) is an independent established prognostic factor in patients with acute myeloid leukemia (AML). Several methods exist to evaluate the presence of residual leukemia cells
Externí odkaz:
https://doaj.org/article/17202d83bbe0411cbe3f0805e3769126